Search for Clinical Trial Results
Hyperphosphatemia - 26 Studies Found
Status | Study |
Completed |
Study Name: Dose Finding Study to Treat High Phosphate Levels in the Blood. Condition: Hyperphosphatemia Date: 2014-03-06 Interventions:
|
Recruiting |
Study Name: Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients Condition:
Date: 2016-01-28 Interventions:
|
Completed |
Study Name: Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia Condition:
Date: 2010-01-25 Interventions:
|
Completed |
Study Name: A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis Condition:
Date: 2007-07-18 Interventions:
|
Completed |
Study Name: A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia Condition:
Date: 2006-12-27 Interventions:
|
Completed |
Study Name: BAY 77-1931 Long-term Extension From Phase II Study Condition: Hyperphosphatemia Date: 2008-10-08 Interventions: Drug: BAY 77-1931 Lanthanum Carbonate (BAY 77-1931) |
Completed |
Study Name: Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Condition: Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Date: 2016-03-03 Interventions: Drug: ASP1585 Oral Other Names: |
Completed |
Study Name: A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia Condition:
Date: 2013-05-07 Interventions:
|
Completed |
Study Name: A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia Condition:
Date: 2013-05-07 Interventions: Drug: PA21 |
Completed |
Study Name: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia Condition:
Date: 2013-05-07 Interventions: Drug: PA21 |